Growth Metrics

Enovis (ENOV) Cash from Investing Activities Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Enovis 1.25 Bn 1.22 Bn 365.49 Mn 12.27%

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 12.27%
Dec 31, 2025 77.56%
Oct 3, 2025 4.04%
Jul 4, 2025 -20.51%
Apr 4, 2025 92.41%
Dec 31, 2024 2.51%
Sep 27, 2024 -241.50%
Jun 28, 2024 68.60%
Mar 29, 2024 -2,220.32%
Dec 31, 2023 -60.14%
Sep 29, 2023 71.07%
Jun 30, 2023 -192.41%
Mar 31, 2023 2.22%
Dec 31, 2022 -38.20%
Sep 30, 2022 -174.45%
Jul 1, 2022 68.76%
Apr 1, 2022 72.53%
Dec 31, 2021 70.50%
Oct 1, 2021 30.83%
Jul 2, 2021 -816.42%
Apr 2, 2021 -243.61%
Dec 31, 2020 -105.70%
Oct 2, 2020 -47.29%
Jul 3, 2020 58.21%
Apr 3, 2020 98.83%
Dec 31, 2019 827.13%
Sep 27, 2019 53.23%
Jun 28, 2019 -124.91%
Mar 29, 2019 -5,763.91%
Dec 31, 2018 -231.15%
Sep 28, 2018 -167.09%
Jun 29, 2018 408.69%
Mar 30, 2018 -361.82%
Dec 31, 2017 515.29%
Sep 29, 2017 -4.69%
Jun 30, 2017 -384.16%
Mar 31, 2017 23.91%
Dec 31, 2016 -35.64%
Sep 30, 2016 91.87%
Jul 1, 2016 -41.23%
Apr 1, 2016 -37.88%
Dec 31, 2015 -33.35%
Sep 25, 2015 -1,081.11%
Jun 26, 2015 99.27%
Mar 27, 2015 11.37%
Dec 31, 2014 94.57%
Sep 26, 2014 41.92%
Jun 27, 2014 -5,437.79%
Mar 28, 2014 29.94%
Dec 31, 2013 -115.56%
Sep 27, 2013 39.54%
Jun 28, 2013 41.12%
Mar 29, 2013 98.93%
Dec 31, 2012 -415.12%
Sep 28, 2012 -1,004.95%
Jun 29, 2012 -798.17%
Mar 30, 2012 -6,502.15%
Dec 31, 2011 -797.60%
Sep 30, 2011 85.94%